Back to search

Article

Engineering NKG2D ligand affinity transforms EGFR-targeted NK cell engagers into high-potency effectors against pancreatic cancer

2026-01-20

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> Pancreatic ductal adenocarcinoma (PDAC) often escapes T cell–mediated immunity through impaired major histocompatibility complex class I (MHC-I) antigen presentation, rendering it largely refractory to current immunotherapies. Because natural killer (NK) cells are capable of eliminating MHC-I–low tumor cells, redirecting NK cytotoxicity represents a promising...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0b9c134a-172b-51c6-a391-72e1788ca23b
DOI
10.21203/rs.3.rs-8589580/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Engineering NKG2D ligand affinity transforms EGFR-targeted NK cell engagers into high-potency effectors against pancreatic cancerDOI 10.21203/rs.3.rs-8589580/v1
Select a neighboring publication to make it the new centre.